OPALINE : A Study Of Morbidity And Mortality At 2 Years

NCT02264665 COMPLETED Results posted

A descriptive, prospective (partly retrospective), multisite, observational study conducted in France in adult patients treated for a well differentiated, unresectable or metastatic, pancreatic neuroendocrine tumor with disease progression.

Details

Lead sponsor	Pfizer
Status	COMPLETED
Enrolment	144
Start date	Tue May 12 2015 00:00:00 GMT+0000 (Coordinated Universal Time)
Completion	Mon Nov 18 2019 00:00:00 GMT+0000 (Coordinated Universal Time)

Conditions

• Pancreatic Neuroendocrine Tumor, Well Differentiated and Progressive

Interventions

• sunitinib
• everolimus
• chemotherapies recommended in france

Countries

France